Jeffrey S. Humphrey's most recent trade in Lantheus Holdings Inc was a trade of 16,188 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lantheus Holdings Inc | Jeffrey S. Humphrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 16,188 | 16,188 | - | - | Stock Option (right to buy) | |
Lantheus Holdings Inc | Jeffrey S. Humphrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 82.63 per share. | 17 Jun 2024 | 9,076 | 9,076 (0%) | 0% | 82.6 | 749,950 | Common Stock |